# PJT Partners Inc.: overview

PJT · NYSE · CIK 1626115 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pjt.md) · [Financials](/companies/pjt/financials.md) · [Filings](/companies/pjt/filings.md) · [Insiders](/companies/pjt/insiders.md)

Latest reported revenue: [$482.7m](/filings/0001193125-26-326245.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 30, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-326245).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [320](/filings/0001193125-25-269723.md) | [471 d](/filings/0001193125-26-076969.md) | [322](/filings/0001193125-26-197485.md) | [401](/filings/0001193125-26-326245.md) | [442](/filings/0001193125-25-269723.md) | [531 d](/filings/0001193125-26-076969.md) | [411](/filings/0001193125-26-197485.md) | [483](/filings/0001193125-26-326245.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [6.9%](/filings/0001193125-25-269723.md) | [10.9% d](/filings/0001193125-26-076969.md) | [16.8%](/filings/0001193125-26-197485.md) | [8.2%](/filings/0001193125-26-326245.md) | [9.0%](/filings/0001193125-25-269723.md) | [10.0% d](/filings/0001193125-26-076969.md) | [14.7%](/filings/0001193125-26-197485.md) | [9.5%](/filings/0001193125-26-326245.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [179 d](/filings/0001193125-25-269723.md) | [195 d](/filings/0001193125-26-076969.md) | [(77.9)](/filings/0001193125-26-197485.md) | [179 d](/filings/0001193125-26-326245.md) | [241 d](/filings/0001193125-25-269723.md) | [139 d](/filings/0001193125-26-076969.md) | [56.0](/filings/0001193125-26-197485.md) | [226 d](/filings/0001193125-26-326245.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [986](/filings/0000950170-24-022152.md) | [1,027](/filings/0000950170-25-029132.md) | [1,146](/filings/0001193125-26-076969.md) | [1,476](/filings/0001193125-26-076969.md) | [1,697](/filings/0001193125-26-076969.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [10.8%](/filings/0000950170-24-022152.md) | [8.8%](/filings/0000950170-25-029132.md) | [7.1%](/filings/0001193125-26-076969.md) | [9.1%](/filings/0001193125-26-076969.md) | [10.6%](/filings/0001193125-26-076969.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [118](/filings/0000950170-24-022152.md) | [239](/filings/0000950170-25-029132.md) | [438](/filings/0001193125-26-076969.md) | [528](/filings/0001193125-26-076969.md) | [480](/filings/0001193125-26-076969.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/pjt/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $615.1m | 4,075,374 |  | Added +382,248 |
| [WASATCH ADVISORS LP](/funds/814133.md) | 2026-06-30 | $223.1m | 1,478,222 |  | Added +653,685 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $206.9m | 1,370,798 |  | Added +103,430 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $168.8m | 1,118,057 |  | Added +69,971 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $159.7m | 1,057,881 |  | Added +354,555 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $159.0m | 1,053,770 |  | Added +87,620 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $119.6m | 792,294 |  | Added +41,259 |
| [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $117.7m | 842,197 |  | Added +710,038 |
| [CONGRESS ASSET MANAGEMENT CO](/funds/897378.md) | 2026-06-30 | $109.2m | 723,474 |  | Added +119,122 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $92.8m | 614,734 |  | Reduced −16,569 |

## Recent filings

[All 843 filings](/companies/pjt/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-07-30 | 20:30 ET | [10-Q](/filings/0001193125-26-326245.md) | Quarterly report, period 2026-06-30 | 0001193125-26-326245 |
| 2026-07-28 | 10:50 ET | [8-K](/filings/0001193125-26-318829.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-318829 |
| 2026-07-16 | 10:50 ET | [8-K](/filings/0001193125-26-305383.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-305383 |
| 2026-06-18 | 20:30 ET | [8-K](/filings/0001193125-26-275959.md) | 5.07 Shareholder vote results | 0001193125-26-275959 |
| 2026-04-30 | 20:30 ET | [10-Q](/filings/0001193125-26-197485.md) | Quarterly report, period 2026-03-31 | 0001193125-26-197485 |
| 2026-04-29 | 20:31 ET | [DEF 14A](/filings/0001628280-26-028424.md) | Proxy statement, period 2025-12-31 | 0001628280-26-028424 |
| 2026-04-28 | 10:50 ET | [8-K](/filings/0001193125-26-183466.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-183466 |
| 2026-02-26 | 21:40 ET | [10-K](/filings/0001193125-26-076969.md) | Annual report, period 2025-12-31 | 0001193125-26-076969 |
| 2026-02-03 | 11:50 ET | [8-K](/filings/0001193125-26-034409.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-034409 |
| 2025-11-26 | 21:30 ET | [8-K](/filings/0001193125-25-300641.md) | 8.01 Other events | 0001193125-25-300641 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-076969.md), filed Feb 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/3547cdf6-b8a4-48a4-8768-18e0226df30c)

## About the filer

- CIK: 1626115
- Tickers: PJT
- Exchange: NYSE
- SIC code: 6282 Investment Advice
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.